What Is the Best Cardiometabolic Supplement Stack?

What Is a Cardiometabolic Supplement Stack?

A cardiometabolic supplement stack is a targeted combination of evidence-supported supplements designed to improve interconnected cardiovascular and metabolic risk factors — including lipid levels, blood sugar, inflammation, and insulin sensitivity. The most effective stacks are built around a small number of well-studied compounds rather than a broad list of unproven ingredients.

This article focuses specifically on which supplements have the strongest evidence for cardiometabolic benefit, how they work, and how to combine them intelligently. For a broader overview of ApoB and cardiometabolic risk, see our main guide to ApoB optimisation.

Key Supplements with the Strongest Evidence

Omega-3 Fatty Acids (EPA and DHA)

Omega-3 fatty acids — primarily EPA and DHA from fish oil — have the most consistent evidence of any supplement for cardiometabolic benefit. Research shows they reliably lower triglycerides, reduce inflammatory markers, and support endothelial function. High-dose EPA (as in prescription icosapentaenoic acid) has demonstrated cardiovascular event reduction in clinical trials, though standard fish oil doses have more modest effects.

For general cardiometabolic support, evidence supports combined EPA and DHA intake of around 1–2g per day. Higher doses specifically for triglyceride lowering are sometimes used under medical supervision. Learn more in our article on whether omega-3 lowers triglycerides.

Berberine

Berberine is a plant-derived compound that activates AMPK — an enzyme that regulates cellular energy balance and plays a central role in glucose and lipid metabolism. Research suggests berberine can meaningfully reduce fasting blood glucose, improve insulin sensitivity, and modestly lower LDL cholesterol and ApoB in some individuals.

Its mechanism overlaps with that of metformin, though direct head-to-head evidence in large human trials is limited. Current evidence is promising but should be interpreted with that caveat. Berberine is also associated with modest reductions in triglycerides. For more detail on its lipid effects, see our article on whether berberine lowers LDL.

Curcumin (Turmeric Extract)

Curcumin, the active compound in turmeric, has well-documented anti-inflammatory properties in cell and animal studies. Human evidence is more limited, partly because curcumin is poorly absorbed without formulation enhancement (such as phospholipid complexes or piperine). Where absorption is addressed, research suggests modest reductions in inflammatory markers such as CRP and improvements in endothelial function.

Curcumin is unlikely to produce large changes in lipid panels alone, but as part of a stack targeting systemic inflammation, it may contribute meaningfully to overall cardiometabolic health.

Resveratrol

Resveratrol activates sirtuins and AMPK pathways associated with metabolic regulation and healthy ageing. Evidence from animal studies is strong, but human trials have shown mixed results — likely due to differences in bioavailability and dosing. It remains a reasonable addition to a cardiometabolic stack at bioavailable doses, but should not be the centrepiece. Human evidence is limited and should be weighted accordingly.

How to Build and Optimise Your Stack

Start with foundational compounds

A practical cardiometabolic stack begins with the supplements that have the most robust human evidence: omega-3s for triglycerides and inflammation, and berberine for glucose and lipid regulation. These two alone address the majority of common cardiometabolic risk factors.

Curcumin (in a bioavailable form) can be added as an anti-inflammatory complement. Together, these three compounds target overlapping but distinct pathways — making them genuinely synergistic rather than redundant.

Personalise based on your risk profile

Blood test results should guide stack construction. Someone with elevated triglycerides and normal glucose may prioritise omega-3s and curcumin. Someone with insulin resistance or elevated fasting glucose may benefit more from berberine as a priority. Reviewing ApoB, triglycerides, fasting insulin, and inflammatory markers provides the clearest picture of where supplementation will have the greatest impact.

Consulting a clinician before starting berberine is advisable, particularly for individuals already managing blood sugar with medication, due to potential additive effects.

Prioritise supplement quality

Third-party tested products with transparent labelling and verified active compound content are worth the additional cost. Bioavailability formulations matter — particularly for curcumin and resveratrol, where standard extracts are poorly absorbed. For omega-3s, triglyceride-form fish oil generally has better absorption than ethyl ester forms.

Combine with lifestyle factors

Supplements support — but do not replace — the lifestyle foundations of cardiometabolic health. Diet quality, regular exercise, sleep, and stress regulation each independently influence lipids, inflammation, and insulin sensitivity. A well-constructed stack produces meaningfully better outcomes when paired with these habits. Learn more in our complete guide to longevity at longevityinsights.co.uk/what-is-longevity/.

Limitations and What Supplements Cannot Do

No supplement stack replaces the impact of sustained lifestyle change or, where indicated, medication. For individuals with significantly elevated ApoB, LDL, or established cardiovascular disease, statin therapy or other pharmacological interventions typically offer far greater risk reduction than supplements alone.

The compounds discussed here are most relevant as adjuncts in moderate-risk individuals, as complements to primary interventions, or as tools for optimising already-reasonable cardiometabolic markers. They should not be used to delay necessary medical evaluation or treatment.

Evidence quality also varies. Omega-3s at high doses have robust trial data. Berberine has solid mechanistic and moderate clinical evidence. Curcumin and resveratrol have weaker human evidence, with strong mechanistic plausibility. This gradient should shape expectations and prioritisation.

References and Resources

Frequently Asked Questions

Conclusion

The most evidence-supported cardiometabolic supplement stack centres on three compounds: omega-3 fatty acids for triglycerides and inflammation, berberine for glucose and lipid regulation, and bioavailable curcumin as an anti-inflammatory complement. Together, these address the key drivers of cardiometabolic risk through distinct but overlapping mechanisms.

No stack is universally optimal. Blood markers, individual risk profile, and existing medications should all shape supplementation decisions. Used consistently alongside sound lifestyle habits, a well-constructed cardiometabolic stack can meaningfully support long-term cardiovascular and metabolic health — but it works best as part of a broader prevention strategy, not as a standalone fix.